SCHEMBL23334692

SCHEMBL23334692

c1ccc(-c2nc(-c3ccc4oc5ccccc5c4c3)cc(-c3cc4ccccc4o3)n2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.43
PLA2G2A P14555 3/20 0.42
PLA2G4A P47712 3/20 0.42
MAPT P10636 4/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
MAOB P27338 2/20 0.41
MCL1 Q07820 1/20 0.41
METAP2 P50579 1/20 0.41
PLA2G10 O15496 1/20 0.40
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
HPGD P15428 4/20 0.40
ALDH1A1 P00352 3/20 0.40
GRM4 Q14833 1/20 0.40
NTSR1 P30989 1/20 0.40
SIRT6 Q8N6T7 1/20 0.40
MAOA P21397 1/20 0.40
ALOX5 P09917 1/20 0.40
KDM4E B2RXH2 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23334932 0.99 PLA2G2A (0.44) CYP19A1PLA2G2APLA2G4AMAPTNPC1
SCHEMBL23334670 0.94 PLA2G2A (0.46) CYP19A1PLA2G2APLA2G4AMAPTNPC1
SCHEMBL23334690 0.90 PLA2G2A (0.45) CYP19A1PLA2G2APLA2G4AMAPTNPC1
SCHEMBL15505923 0.89 MAPT (0.49) PLA2G2APLA2G4AMAPTNPC1RAB9A
SCHEMBL21476271 0.88 MAOB (0.51) CYP19A1PLA2G2APLA2G4ANPC1RAB9A
SCHEMBL21476596 0.88 PLA2G2A (0.45) CYP19A1PLA2G2APLA2G4AMAPTNPC1
SCHEMBL18698037 0.88 MEN1 (0.51) PLA2G2APLA2G4AMAPTNPC1RAB9A
SCHEMBL23334644 0.88 PLA2G2A (0.47) CYP19A1PLA2G2APLA2G4AMAPTNPC1
SCHEMBL21480594 0.88 MCL1 (0.42) CYP19A1PLA2G2APLA2G4AMAPTNPC1
SCHEMBL23335209 0.87 CYP19A1 (0.43) CYP19A1PLA2G2APLA2G4AMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210130336-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2021-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210130336-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE L1CAM, MLX, LEF1 CYP19A1 931/4885PLA2G2A 3064/4885PLA2G4A 4054/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.